drugset
drugset / Trial / NCT04111289

Effect of Upstream High Bolus Dose of Tirofiban in Primary PCI for the Patients With STEMI on Short Term Outcome

NCT04111289 ↗

Phase 1/2 Unknown 150 enrolled Assiut University
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of the study to investigate the impact of upstream HBD of Tirofiban on short outcome of STEMI patient.

Timeline

Start
2019-11-01
Primary completion
2021-09-30
Completion
2022-01-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tirofiban Other / unclassified 0.15 ug/kg Intravenous

Indications

No indication recorded.